nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—PTGER3—polycystic ovary syndrome	0.564	0.704	CbGaD
Bimatoprost—AKR1C3—polycystic ovary syndrome	0.237	0.296	CbGaD
Bimatoprost—PTGFR—corpus luteum—polycystic ovary syndrome	0.0238	0.322	CbGeAlD
Bimatoprost—PTGFR—ovarian follicle—polycystic ovary syndrome	0.0186	0.252	CbGeAlD
Bimatoprost—PTGER3—uterus—polycystic ovary syndrome	0.00212	0.0287	CbGeAlD
Bimatoprost—PTGER3—adipose tissue—polycystic ovary syndrome	0.00207	0.0281	CbGeAlD
Bimatoprost—PTGER1—female gonad—polycystic ovary syndrome	0.00198	0.0268	CbGeAlD
Bimatoprost—PTGER3—adrenal gland—polycystic ovary syndrome	0.00186	0.0252	CbGeAlD
Bimatoprost—PTGER1—endocrine gland—polycystic ovary syndrome	0.00184	0.0249	CbGeAlD
Bimatoprost—PTGER3—female gonad—polycystic ovary syndrome	0.00174	0.0235	CbGeAlD
Bimatoprost—PTGFR—uterus—polycystic ovary syndrome	0.0017	0.023	CbGeAlD
Bimatoprost—AKR1C3—adrenal cortex—polycystic ovary syndrome	0.00167	0.0227	CbGeAlD
Bimatoprost—PTGFR—adipose tissue—polycystic ovary syndrome	0.00166	0.0225	CbGeAlD
Bimatoprost—PTGER3—endocrine gland—polycystic ovary syndrome	0.00161	0.0219	CbGeAlD
Bimatoprost—Dinoprost Tromethamine—PTGER3—polycystic ovary syndrome	0.00155	0.327	CrCbGaD
Bimatoprost—AKR1C3—endometrium—polycystic ovary syndrome	0.0015	0.0203	CbGeAlD
Bimatoprost—PTGFR—adrenal gland—polycystic ovary syndrome	0.00149	0.0202	CbGeAlD
Bimatoprost—Iloprost—PLAT—polycystic ovary syndrome	0.00144	0.303	CrCbGaD
Bimatoprost—PTGFR—female gonad—polycystic ovary syndrome	0.00139	0.0188	CbGeAlD
Bimatoprost—AKR1C3—uterus—polycystic ovary syndrome	0.00138	0.0187	CbGeAlD
Bimatoprost—AKR1C3—pituitary gland—polycystic ovary syndrome	0.00135	0.0183	CbGeAlD
Bimatoprost—AKR1C3—adipose tissue—polycystic ovary syndrome	0.00135	0.0183	CbGeAlD
Bimatoprost—PTGFR—endocrine gland—polycystic ovary syndrome	0.00129	0.0175	CbGeAlD
Bimatoprost—AKR1C3—adrenal gland—polycystic ovary syndrome	0.00121	0.0164	CbGeAlD
Bimatoprost—Dinoprostone—PTGER3—polycystic ovary syndrome	0.00119	0.251	CrCbGaD
Bimatoprost—AKR1C3—female gonad—polycystic ovary syndrome	0.00113	0.0153	CbGeAlD
Bimatoprost—AKR1C3—vagina—polycystic ovary syndrome	0.00112	0.0152	CbGeAlD
Bimatoprost—Dinoprostone—CYP11A1—polycystic ovary syndrome	0.00037	0.0778	CrCbGaD
Bimatoprost—Dinoprostone—CYP19A1—polycystic ovary syndrome	0.000191	0.0403	CrCbGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTGER3—polycystic ovary syndrome	5.48e-05	0.000457	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LHCGR—polycystic ovary syndrome	5.48e-05	0.000457	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	5.47e-05	0.000456	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.46e-05	0.000455	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.43e-05	0.000452	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—STAR—polycystic ovary syndrome	5.38e-05	0.000449	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.34e-05	0.000446	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.34e-05	0.000445	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5.32e-05	0.000443	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.31e-05	0.000443	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.27e-05	0.000439	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.19e-05	0.000433	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.16e-05	0.00043	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.12e-05	0.000427	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.12e-05	0.000427	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FST—polycystic ovary syndrome	5.06e-05	0.000422	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.03e-05	0.00042	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.02e-05	0.000418	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ADRB3—polycystic ovary syndrome	5e-05	0.000417	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—INHBB—polycystic ovary syndrome	4.99e-05	0.000416	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	4.97e-05	0.000415	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LHB—polycystic ovary syndrome	4.94e-05	0.000412	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—INHBB—polycystic ovary syndrome	4.89e-05	0.000408	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.84e-05	0.000403	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.83e-05	0.000403	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—HMMR—polycystic ovary syndrome	4.8e-05	0.0004	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—INHBB—polycystic ovary syndrome	4.72e-05	0.000393	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKR1C1—polycystic ovary syndrome	4.72e-05	0.000393	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.68e-05	0.00039	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.67e-05	0.000389	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.66e-05	0.000389	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SCT—polycystic ovary syndrome	4.63e-05	0.000386	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—HSD3B1—polycystic ovary syndrome	4.57e-05	0.000381	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.57e-05	0.000381	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.56e-05	0.00038	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.55e-05	0.000379	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.52e-05	0.000377	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.45e-05	0.000371	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.42e-05	0.000368	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.4e-05	0.000367	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—FGF18—polycystic ovary syndrome	4.38e-05	0.000365	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FGF18—polycystic ovary syndrome	4.34e-05	0.000362	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RBP4—polycystic ovary syndrome	4.34e-05	0.000362	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RBP4—polycystic ovary syndrome	4.3e-05	0.000359	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.29e-05	0.000357	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FSHR—polycystic ovary syndrome	4.25e-05	0.000354	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.24e-05	0.000353	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—LHB—polycystic ovary syndrome	4.17e-05	0.000348	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—POMC—polycystic ovary syndrome	4.16e-05	0.000347	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FSHR—polycystic ovary syndrome	4.16e-05	0.000346	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.13e-05	0.000344	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—HSD3B2—polycystic ovary syndrome	4.08e-05	0.00034	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—POMC—polycystic ovary syndrome	4.07e-05	0.000339	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.04e-05	0.000337	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—YAP1—polycystic ovary syndrome	4.02e-05	0.000335	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FSHR—polycystic ovary syndrome	4.01e-05	0.000334	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—GAB1—polycystic ovary syndrome	4e-05	0.000333	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.99e-05	0.000333	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GAB1—polycystic ovary syndrome	3.96e-05	0.00033	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKR1C1—polycystic ovary syndrome	3.95e-05	0.000329	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.91e-05	0.000326	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NAMPT—polycystic ovary syndrome	3.89e-05	0.000324	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.88e-05	0.000324	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.8e-05	0.000317	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—INSR—polycystic ovary syndrome	3.79e-05	0.000316	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FST—polycystic ovary syndrome	3.78e-05	0.000316	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.77e-05	0.000314	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.76e-05	0.000314	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.74e-05	0.000312	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FST—polycystic ovary syndrome	3.7e-05	0.000309	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LHB—polycystic ovary syndrome	3.69e-05	0.000308	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.68e-05	0.000307	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.67e-05	0.000306	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.66e-05	0.000305	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—SULT2A1—polycystic ovary syndrome	3.63e-05	0.000303	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LHB—polycystic ovary syndrome	3.62e-05	0.000301	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.61e-05	0.000301	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.6e-05	0.0003	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FST—polycystic ovary syndrome	3.57e-05	0.000298	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TNRC6B—polycystic ovary syndrome	3.57e-05	0.000298	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.54e-05	0.000295	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.53e-05	0.000295	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.53e-05	0.000294	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—RRM2—polycystic ovary syndrome	3.52e-05	0.000293	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PGR—polycystic ovary syndrome	3.51e-05	0.000292	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.5e-05	0.000292	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.49e-05	0.000291	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LHB—polycystic ovary syndrome	3.49e-05	0.000291	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SCT—polycystic ovary syndrome	3.46e-05	0.000289	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.42e-05	0.000285	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.42e-05	0.000285	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.42e-05	0.000285	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.41e-05	0.000284	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—YAP1—polycystic ovary syndrome	3.39e-05	0.000283	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SCT—polycystic ovary syndrome	3.39e-05	0.000282	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.34e-05	0.000279	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.3e-05	0.000275	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.3e-05	0.000275	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SCT—polycystic ovary syndrome	3.27e-05	0.000273	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PLAT—polycystic ovary syndrome	3.26e-05	0.000272	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GHRL—polycystic ovary syndrome	3.26e-05	0.000272	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NAMPT—polycystic ovary syndrome	3.26e-05	0.000272	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGF18—polycystic ovary syndrome	3.24e-05	0.000271	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.24e-05	0.00027	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.23e-05	0.000269	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP11A1—polycystic ovary syndrome	3.22e-05	0.000268	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RBP4—polycystic ovary syndrome	3.22e-05	0.000268	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	3.2e-05	0.000267	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.2e-05	0.000266	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGF18—polycystic ovary syndrome	3.18e-05	0.000265	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.17e-05	0.000264	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RBP4—polycystic ovary syndrome	3.15e-05	0.000263	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.14e-05	0.000262	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	3.14e-05	0.000261	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.12e-05	0.00026	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ATF1—polycystic ovary syndrome	3.11e-05	0.000259	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.1e-05	0.000259	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGF18—polycystic ovary syndrome	3.06e-05	0.000255	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TCF7L2—polycystic ovary syndrome	3.06e-05	0.000255	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RBP4—polycystic ovary syndrome	3.04e-05	0.000253	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.03e-05	0.000253	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.02e-05	0.000252	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SLC2A4—polycystic ovary syndrome	3.01e-05	0.000251	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—YAP1—polycystic ovary syndrome	3e-05	0.00025	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP17A1—polycystic ovary syndrome	2.99e-05	0.00025	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GAB1—polycystic ovary syndrome	2.96e-05	0.000247	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.94e-05	0.000245	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.9e-05	0.000242	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NGFR—polycystic ovary syndrome	2.87e-05	0.000239	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PRL—polycystic ovary syndrome	2.87e-05	0.000239	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—POMC—polycystic ovary syndrome	2.85e-05	0.000238	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PRL—polycystic ovary syndrome	2.85e-05	0.000237	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—YAP1—polycystic ovary syndrome	2.84e-05	0.000237	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—INSR—polycystic ovary syndrome	2.83e-05	0.000236	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GAB1—polycystic ovary syndrome	2.8e-05	0.000233	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—INSR—polycystic ovary syndrome	2.77e-05	0.000231	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.74e-05	0.000229	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.7e-05	0.000225	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.69e-05	0.000224	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—INSR—polycystic ovary syndrome	2.68e-05	0.000223	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.65e-05	0.000221	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.63e-05	0.00022	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PGR—polycystic ovary syndrome	2.62e-05	0.000219	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.59e-05	0.000216	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—TH—polycystic ovary syndrome	2.59e-05	0.000216	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PGR—polycystic ovary syndrome	2.57e-05	0.000214	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—SLC2A4—polycystic ovary syndrome	2.52e-05	0.00021	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GNAS—polycystic ovary syndrome	2.5e-05	0.000209	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.5e-05	0.000209	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PGR—polycystic ovary syndrome	2.48e-05	0.000207	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GHRL—polycystic ovary syndrome	2.44e-05	0.000203	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PLAT—polycystic ovary syndrome	2.44e-05	0.000203	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NCOR1—polycystic ovary syndrome	2.4e-05	0.0002	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.39e-05	0.000199	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.39e-05	0.000199	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.38e-05	0.000199	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP19A1—polycystic ovary syndrome	2.37e-05	0.000197	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NRG1—polycystic ovary syndrome	2.36e-05	0.000197	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.35e-05	0.000196	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NRG1—polycystic ovary syndrome	2.34e-05	0.000195	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ATF1—polycystic ovary syndrome	2.33e-05	0.000194	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PLAT—polycystic ovary syndrome	2.3e-05	0.000192	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GHRL—polycystic ovary syndrome	2.3e-05	0.000192	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.3e-05	0.000192	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.28e-05	0.00019	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.27e-05	0.000189	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.26e-05	0.000188	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.22e-05	0.000185	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.21e-05	0.000184	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ATF1—polycystic ovary syndrome	2.2e-05	0.000183	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NGFR—polycystic ovary syndrome	2.15e-05	0.000179	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.14e-05	0.000179	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—POMC—polycystic ovary syndrome	2.13e-05	0.000178	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PRL—polycystic ovary syndrome	2.13e-05	0.000177	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTHFR—polycystic ovary syndrome	2.13e-05	0.000177	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GNAS—polycystic ovary syndrome	2.11e-05	0.000176	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.1e-05	0.000175	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.09e-05	0.000174	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PRL—polycystic ovary syndrome	2.08e-05	0.000174	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.05e-05	0.000171	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NGFR—polycystic ovary syndrome	2.03e-05	0.000169	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IRS2—polycystic ovary syndrome	2.02e-05	0.000169	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.02e-05	0.000168	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NCOR1—polycystic ovary syndrome	2.01e-05	0.000168	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PRL—polycystic ovary syndrome	2.01e-05	0.000168	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.01e-05	0.000167	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IRS2—polycystic ovary syndrome	2e-05	0.000167	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.98e-05	0.000165	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LEP—polycystic ovary syndrome	1.96e-05	0.000164	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP1A1—polycystic ovary syndrome	1.91e-05	0.000159	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.91e-05	0.000159	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GNAS—polycystic ovary syndrome	1.87e-05	0.000156	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.83e-05	0.000153	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.78e-05	0.000149	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—MTHFR—polycystic ovary syndrome	1.78e-05	0.000148	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GNAS—polycystic ovary syndrome	1.77e-05	0.000147	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IRS1—polycystic ovary syndrome	1.76e-05	0.000147	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NRG1—polycystic ovary syndrome	1.75e-05	0.000146	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.75e-05	0.000146	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.75e-05	0.000146	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.71e-05	0.000143	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—INS—polycystic ovary syndrome	1.69e-05	0.000141	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—POMC—polycystic ovary syndrome	1.69e-05	0.000141	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.68e-05	0.00014	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—INS—polycystic ovary syndrome	1.68e-05	0.00014	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NRG1—polycystic ovary syndrome	1.65e-05	0.000138	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT2—polycystic ovary syndrome	1.63e-05	0.000136	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.62e-05	0.000135	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.62e-05	0.000135	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SERPINE1—polycystic ovary syndrome	1.55e-05	0.000129	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.54e-05	0.000128	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS2—polycystic ovary syndrome	1.5e-05	0.000125	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.47e-05	0.000122	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LEP—polycystic ovary syndrome	1.47e-05	0.000122	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARG—polycystic ovary syndrome	1.44e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LEP—polycystic ovary syndrome	1.44e-05	0.00012	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—POMC—polycystic ovary syndrome	1.42e-05	0.000119	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS2—polycystic ovary syndrome	1.42e-05	0.000118	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—INS—polycystic ovary syndrome	1.42e-05	0.000118	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LEP—polycystic ovary syndrome	1.39e-05	0.000116	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS1—polycystic ovary syndrome	1.31e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.28e-05	0.000107	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—POMC—polycystic ovary syndrome	1.26e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—INS—polycystic ovary syndrome	1.25e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.24e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.24e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—POMC—polycystic ovary syndrome	1.23e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—INS—polycystic ovary syndrome	1.23e-05	0.000102	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1—polycystic ovary syndrome	1.21e-05	0.000101	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT2—polycystic ovary syndrome	1.21e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—POMC—polycystic ovary syndrome	1.19e-05	9.92e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.19e-05	9.89e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.19e-05	9.89e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—INS—polycystic ovary syndrome	1.18e-05	9.87e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.15e-05	9.6e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.14e-05	9.54e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.14e-05	9.54e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.13e-05	9.39e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.09e-05	9.06e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.06e-05	8.83e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—polycystic ovary syndrome	9.27e-06	7.73e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.07e-06	7.57e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.92e-06	6.6e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.75e-06	6.46e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.48e-06	6.23e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—polycystic ovary syndrome	7.39e-06	6.16e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—polycystic ovary syndrome	7.32e-06	6.11e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—polycystic ovary syndrome	5.48e-06	4.57e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—polycystic ovary syndrome	5.36e-06	4.47e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—polycystic ovary syndrome	5.17e-06	4.31e-05	CbGpPWpGaD
